Skip to Main Content

Paper Details

Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.
Acta Neuropathol
29
2021
1p/19q, DNA, IDH, IDH mutation, IDH mutations, IDH-mutations, IDH1, IDH1-R132H IDH1/2 mutations, IDH1-R132H mutations, IDH1/2, IDH1R132H, IDH2, Patients, R132H, R132H IDH1/2, astrocytoma, astrocytomas, glioma, gliomas, hotspots, isocitrate, isocitrate dehydrogenase genes, non-R132H IDH1/2-mutated tumours, patient, patients, tumour, tumours
Author NameAffiliation
Marc SansonSorbonne Universites UPMC University of Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle (ICM)-Hopital Pitie-Salpetriere
C Leland RogersBarrow Neurological Institute
Michael WellerUniversity Hospital and University of Zurich
Youri HoogstrateBrain Tumor Center at Erasmus MC Cancer Institute Rotterdam
Michael A VogelbaumMoffitt Cancer Center
Warren P MasonPrincess Margaret Cancer Centre, University of Toronto
Johan M KrosErasmus University Medical Center
Kenneth AldapePrincess Margaret Cancer Centre, University of Toronto
Kenneth AldapePrincess Margaret Cancer Centre, University of Toronto
Pim J FrenchBrain Tumor Center at Erasmus MC Cancer Institute Rotterdam
  • 1 - 10

Datasets

Release 1.2